RT Journal Article
SR Electronic
T1 Pharmacogenetics of the Arylamine<em>N</em>-Acetyltransferases: A Symposium in Honor of Wendell W. Weber
JF Drug Metabolism and Disposition
JO Drug Metab Dispos
FD American Society for Pharmacology and Experimental Therapeutics
SP 1425
OP 1432
VO 28
IS 12
A1 David W. Hein
A1 Charlene A. McQueen
A1 Denis M. Grant
A1 Geoffrey H. Goodfellow
A1 Fred F. Kadlubar
A1 Wendell W. Weber
YR 2000
UL http://dmd.aspetjournals.org/content/28/12/1425.abstract
AB This article is a report on a symposium sponsored by the American Society for Pharmacology and Experimental Therapeutics presented at the joint meeting of the American Society for Biochemistry and Molecular Biology and the American Society for Pharmacology and Experimental Therapeutics, June 4–8, Boston, Massachusetts. The presentations focused on the pharmacogenetics of the NAT1 and NAT2 arylamineN-acetyltransferases, including developmental regulation, structure-function relationships, and their possible role in susceptibility to breast, colon, and pancreatic cancers. The symposium honored Wendell W. Weber for over 35 years of leadership and scientific advancement in pharmacogenetics and was highlighted by his overview of the historical development of the field. The American Society for Pharmacology and Experimental Therapeutics